FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229443523> ?p ?o ?g. }

• W4229443523 endingPage "115358" @default.
• W4229443523 startingPage "115358" @default.
• W4229443523 abstract "Tacrolimus (TAC) was widely used in various renal diseases while high recurrence rate and high expense restricted its applications. Traditional herbal medicine has become increasingly popular as an adjuvant therapy to minimize the adverse effects of TAC. Colquhounia root tablet (CRT), a prescribed drug prepared from the water extract of the peeled root of Tripterygium hypoglaucum (H. Lév.) Hutch., showed excellent anti-inflammatory, analgesic and immunosuppressive pharmacological properties. TAC used in combination with CRT was substantially more efficacious and safer than the monotherapy for the treatment of nephrotic syndrome. However, studies on their herb-drug interaction were scanty.The study was proposed to examine the effect of CRT on the pharmacokinetics of TAC in rats and identify the key natural constituents in CRT that affected the metabolism of TAC.TAC was orally and intravenously administered to rats alone or in combination with CRT and the pharmacokinetic parameters of TAC were compared. After pretreatment with CRT for 15 d, the expressions of the drug-metabolizing enzymes (DMEs), drug transporters (DTs) and nuclear receptors (NRs) were determined by polymerase chain reaction and western blotting and compared with the control group. The hepatic microsomal incubation system was employed to confirm the inhibitory effects of CRT and its major components on rat cytochrome P450 (CYP) 3A2. The roles of the primary components in the regulation of human CYP3A4 and mouse P-gp activities were evaluated by using docking analysis.The blood concentrations of TAC were significantly increased in a dose- and pretreatment time-dependent manner after combined administration of CRT. The maximal effect was found at 300 mg/kg (43.70 ± 8.77 ng/mL and 141.45 ± 21.58 h·ng/mL) in a single dose run and the pharmacokinetic parameters gradually returned to the normal levels at 24 h interval of long-term CRT pretreatment. In contrast, CRT had no effect on the pharmacokinetics of intravenous TAC. Further study indicated that the mRNA and protein expressions of DMEs and DTs, such as CYP3A1, CYP3A2, P-glycoprotein (P-gp) and multidrug resistance-associated protein 2 in rat intestine and liver were down-regulated, whereas the expressions of NRs like constitutive androstane receptor and pregnane X receptor were up-regulated after multiple oral doses of CRT. Molecular docking showed the binding potency of five CRT major constituents with both human CYP3A4 and mouse P-gp. Celastrol, wilforgine and wilforine were the strongest inhibitors towards midazolam metabolism in rat liver microsomes, with the 50% inhibition concentrations being at 8.33 μM, 22.18 μM and 22.22 μM, respectively.Our results revealed that co-dosing of CRT could lead to a significant increase in blood concentration of TAC and this effect could be ascribed to the resultant co-regulation of DMEs, DTs and NRs. Our study provided an experimental basis for the combination use of CRT and TAC in clinical practice." @default.
• W4229443523 created "2022-05-11" @default.
• W4229443523 creator A5068194864 @default.
• W4229443523 creator A5071354778 @default.
• W4229443523 creator A5084469164 @default.
• W4229443523 creator A5087036906 @default.
• W4229443523 date "2022-08-01" @default.
• W4229443523 modified "2023-09-23" @default.
• W4229443523 title "Inhibitory effects of traditional Chinese medicine colquhounia root tablet on the pharmacokinetics of tacrolimus in rats" @default.
• W4229443523 cites W1498240790 @default.
• W4229443523 cites W1718233288 @default.
• W4229443523 cites W1975520976 @default.
• W4229443523 cites W2007781848 @default.
• W4229443523 cites W2008423993 @default.
• W4229443523 cites W2018074201 @default.
• W4229443523 cites W2018747296 @default.
• W4229443523 cites W2023096370 @default.
• W4229443523 cites W2028618237 @default.
• W4229443523 cites W2035101957 @default.
• W4229443523 cites W2039673319 @default.
• W4229443523 cites W2045121044 @default.
• W4229443523 cites W2049967713 @default.
• W4229443523 cites W2052715775 @default.
• W4229443523 cites W2053186448 @default.
• W4229443523 cites W2058689557 @default.
• W4229443523 cites W2059318722 @default.
• W4229443523 cites W2064815573 @default.
• W4229443523 cites W2073720395 @default.
• W4229443523 cites W2075300546 @default.
• W4229443523 cites W2075540033 @default.
• W4229443523 cites W2077854783 @default.
• W4229443523 cites W2080836582 @default.
• W4229443523 cites W2100583397 @default.
• W4229443523 cites W2105004883 @default.
• W4229443523 cites W2109062146 @default.
• W4229443523 cites W2115934138 @default.
• W4229443523 cites W2146734098 @default.
• W4229443523 cites W2152064050 @default.
• W4229443523 cites W2260590281 @default.
• W4229443523 cites W2263265497 @default.
• W4229443523 cites W2287133488 @default.
• W4229443523 cites W2333716667 @default.
• W4229443523 cites W2346751630 @default.
• W4229443523 cites W2555239882 @default.
• W4229443523 cites W2570499601 @default.
• W4229443523 cites W2602137820 @default.
• W4229443523 cites W2626451148 @default.
• W4229443523 cites W2758941899 @default.
• W4229443523 cites W2792371826 @default.
• W4229443523 cites W2792486094 @default.
• W4229443523 cites W2792953005 @default.
• W4229443523 cites W2793311913 @default.
• W4229443523 cites W2796891994 @default.
• W4229443523 cites W2797721776 @default.
• W4229443523 cites W2883446908 @default.
• W4229443523 cites W2947966654 @default.
• W4229443523 cites W2948165774 @default.
• W4229443523 cites W3000691799 @default.
• W4229443523 cites W3035999093 @default.
• W4229443523 cites W3047375034 @default.
• W4229443523 cites W3093315078 @default.
• W4229443523 cites W3130432488 @default.
• W4229443523 cites W3190979953 @default.
• W4229443523 cites W3215207933 @default.
• W4229443523 doi "https://doi.org/10.1016/j.jep.2022.115358" @default.
• W4229443523 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35551976" @default.
• W4229443523 hasPublicationYear "2022" @default.
• W4229443523 type Work @default.
• W4229443523 citedByCount "2" @default.
• W4229443523 countsByYear W42294435232023 @default.
• W4229443523 crossrefType "journal-article" @default.
• W4229443523 hasAuthorship W4229443523A5068194864 @default.
• W4229443523 hasAuthorship W4229443523A5071354778 @default.
• W4229443523 hasAuthorship W4229443523A5084469164 @default.
• W4229443523 hasAuthorship W4229443523A5087036906 @default.
• W4229443523 hasConcept C109650736 @default.
• W4229443523 hasConcept C112705442 @default.
• W4229443523 hasConcept C126322002 @default.
• W4229443523 hasConcept C2777056448 @default.
• W4229443523 hasConcept C2780035454 @default.
• W4229443523 hasConcept C2909675724 @default.
• W4229443523 hasConcept C2911091166 @default.
• W4229443523 hasConcept C526171541 @default.
• W4229443523 hasConcept C62231903 @default.
• W4229443523 hasConcept C71924100 @default.
• W4229443523 hasConcept C97320921 @default.
• W4229443523 hasConcept C98274493 @default.
• W4229443523 hasConceptScore W4229443523C109650736 @default.
• W4229443523 hasConceptScore W4229443523C112705442 @default.
• W4229443523 hasConceptScore W4229443523C126322002 @default.
• W4229443523 hasConceptScore W4229443523C2777056448 @default.
• W4229443523 hasConceptScore W4229443523C2780035454 @default.
• W4229443523 hasConceptScore W4229443523C2909675724 @default.
• W4229443523 hasConceptScore W4229443523C2911091166 @default.
• W4229443523 hasConceptScore W4229443523C526171541 @default.
• W4229443523 hasConceptScore W4229443523C62231903 @default.
• W4229443523 hasConceptScore W4229443523C71924100 @default.
• W4229443523 hasConceptScore W4229443523C97320921 @default.

• next